Point of Care Molecular Diagnostics Market Size Analysis To 2028

    Point-of-Care Molecular Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product & Services (Assays and Kits, Instruments, and Services and Software), Technology [PCR, Isothermal Nucleic Acid Amplification Technology (INAAT), and Other Technologies], Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Other Applications), and End User (Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes, and Others) Geography

    Publication Month: Oct 2021 | Report Code: TIPRE00003144 | No. of Pages: 208 | Category: Medical Device | Status: Published

    The point-of-care molecular diagnostics market is projected to reach US$ 5,381.18 million by 2028 from US$ 2,230.94 million in 2021; it is expected to grow at a CAGR of 13.4% from 2021 to 2028.

    The growth of the market is attributed to the growing demand for specific viral detection methods that consume less time for timely infection control and rising incidence of infectious diseases. However, the pricing pressures owing to reimbursement cuts restrain the Point-of-Care Molecular Diagnostics market growth. Point-of-care molecular diagnostics comprises portable devices and assays & kits to detect and diagnose diseases from human samples, such as throat swab, blood, serum, and stool. Molecular diagnostics are shifting from centralized laboratories to decentralized point-of-care molecular testing, due to its simplicity, convenience, rapid turnaround time, and potential to improve patient outcomes. Owing to these advantages, it can be applied for diagnosis in low-resource or remote areas.

    Strategic Insights

    The continuous spread of the disease has led to an elevated demand for advanced diagnostic solutions in Europe, thus boosting the adoption of point-of-care molecular diagnostic kits. Moreover, uninterrupted investments and business activities by industry players are also boosting the point-of-care molecular diagnostic market growth. In 2020, European Medicines Agency (EMA) approved ~97 medicines for the marketing authorization, of which 39 were novel drugs. In October 2020, Eurofins introduced PCR-based COVID-19 diagnostic tests with at-home, self-sampling options, in the for European market.

    Lucrative Regions for Point-of-Care Molecular Diagnostics Market

    Lucrative Regions for Point-of-Care Molecular Diagnostics Market

    Get more information on this report :



    Market Insights

    Rising Incidence of Infectious Diseases Fuels Point-of-Care Molecular Diagnostics Market Growth

    The rising spread of infectious diseases increases the level and rate of testing. Moving molecular diagnostic testing for infectious diseases from laboratories to the point-of-care settings has the potential to revolutionize the rate and amount of testing to be performed. Molecular diagnostics is a more sensitive product and services that allows the detection of smaller concentrations of infectious pathogens, allowing diseases detection earlier than previously allowed. Point-of-care molecular diagnostics offers the potential to minimize the time required to get an actionable result and promote early infection detection, appropriate infection control measures, and enrollment into therapy clinical trials. The rising prevalence of influenza A/B, respiratory syncytial virus (RSV), and hospital-acquired infections (HAIs) boosts the demand for point-of-care molecular testing. Influenza and respiratory syncytial virus (RSV) point-of-care testing can improve patient treatment and infection control. Recently, point-of-care molecular diagnostics played a crucial role in detecting the COVID-19 infection. For COVID-19 infection detection, RT-PCR-based diagnostic tests are time-consuming, expensive, and require advanced equipment and specialized personnel. The high cost of diagnosis and the scarcity of test kits made it difficult to monitor the community transmission. As a result, rapid, affordable, and effective approaches for detecting COVID-19 viral infection in people were needed urgently. The easy and effective point-of-care molecular diagnostic devices allow on-site testing, which aids in the prevention of infection and control of its spread. Therefore, the rising demand for rapid and effective point-of-care molecular kits to detect infectious diseases drives the market growth.

    Product & Services -Based Insights

    Based on product & services, the point-of-care molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment holds the largest share of the market and is anticipated to register the highest CAGR during 2021–2028. The assays and kits help in the early diagnosis of respiratory tract infections and women’s health and sexual health conditions. Also, they are used in various applications such as studying disease pathways, screening for potential drug candidates, and evaluating biopharmaceutical production processes.

    Point-of-Care Molecular Diagnostics Market, by Product & Services – 2021 and 2028

    Point-of-Care Molecular Diagnostics Market, by Product & Services – 2021 and 2028

    Get more information on this report :



    Technology-Based Insights

    Based on technology, the point-of-care molecular diagnostics market is segmented into PCR, isothermal nucleic acid amplification technology (INAAT), and other technologies. The PCR segment holds the largest share of the market, whereas the isothermal nucleic acid amplification technology (INAAT)segment is anticipated to register the highest CAGR in the market during the forecast period.

    Application-Based Insights

    Based on application, the point-of-care molecular diagnostics market is segmented into infectious diseases, oncology, hematology, prenatal testing, endocrinology, and other applications. The infectious diseases segment holds the largest share of the market. However, the oncology segment is anticipated to register the highest CAGR in the market during the forecast period.

    End User-Based Insights

    Based on end user, the point-of-care molecular diagnostics market is segmented into hospitals and clinics, diagnostic laboratories, research and academic institutes, and others. The diagnostic laboratories segment holds the largest market share and is estimated to register the highest CAGR during the forecast period. The market growth for this segment is attributed to the innovations in point-of-care molecular diagnostics.

    Companies operating in the point-of-care molecular diagnostics market are adopting the product innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

    Point-of-Care Molecular Diagnostics Market – by Product & Services

    • Assays and Kits
    • Instruments
    • Services and Software

    Point-of-Care Molecular Diagnostics Market – by Technology

    • PCR
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Other Technologies

    Point-of-Care Molecular Diagnostics Market – by Application

    • Infectious Diseases
    • Oncology
    • Hematology
    • Prenatal Testing
    • Endocrinology
    • Other Applications

    Point-of-Care Molecular Diagnostics Market – by End User

    • Hospitals and Clinics
    • Diagnostic Laboratories
    • Research and Academic Institutes
    • Others

    Point-of-Care Molecular Diagnostics Market– by Geography

    • North America

      • US
      • Canada
      • Mexico
    • Europe

      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)

      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East and Africa (MEA)

      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South and Central America (SCAM)

      • Brazil
      • Argentina
      • Rest of SCAM

    Company Profiles

    • bioMérieux SA
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • Enzo Biochem, Inc.
    • Abbott
    • binx health, Inc.
    • Meridian BioScience, Inc
    • Biocartis
    • Quidel Corporation
    • Bio-Rad Laboratories, Inc.

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Point-of-Care Molecular Diagnostics Market – By Product and Services

    1.3.2 Global Point-of-Care Molecular Diagnostics Market – By Technology

    1.3.3 Global Point-of-Care Molecular Diagnostics Market – By Application

    1.3.4 Global Point-of-Care Molecular Diagnostics Market – By End User

    1.3.5 Global Point-of-Care Molecular Diagnostics Market– By Geography

    2. Global Point-of-Care Molecular Diagnostics Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Point-of-Care Molecular Diagnostics Market– Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America – PEST Analysis

    4.2.2 Europe– PEST Analysis

    4.2.3 Asia Pacific – PEST Analysis

    4.2.4 Middle East and Africa – PEST Analysis

    4.2.5 South and Central America (SCAM) – PEST Analysis

    4.3 Experts Opinion

    5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics

    5.1 Market Drivers

    5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control

    5.1.2 Rising Incidences of Infectious Diseases

    5.2 Market Restraints

    5.2.1 Pricing Pressures owing to Reimbursement Cuts

    5.3 Market Opportunities

    5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics

    5.4 Future Trends

    5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting

    5.5 Impact Analysis

    6. Point-of-Care Molecular Diagnostics Market– Global Analysis

    6.1 Global Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis

    6.2 Global Point-of-Care Molecular Diagnostics Market, By Geography - Forecast and Analysis

    6.3 Market Positioning of Key Players

    7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product and Services

    7.1 Overview

    7.2 Point-of-Care Molecular Diagnostics Market, by Product and Services 2021 & 2028 (%)

    7.3 Assays and Kits

    7.3.1 Overview

    7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.4 Instruments

    7.4.1 Overview

    7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.5 Services and Software

    7.5.1 Overview

    7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology

    8.1 Overview

    8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2021 & 2028 (%)

    8.3 PCR

    8.3.1 Overview

    8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)

    8.4.1 Overview

    8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.5 Others

    8.5.1 Overview

    8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9. Point-of-Care Molecular Diagnostics Market Analysis – By Application

    9.1 Overview

    9.2 Point-of-Care Molecular Diagnostics Market, by Application 2021 & 2028 (%)

    9.3 Infectious Disease

    9.3.1 Overview

    9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9.4 Oncology

    9.4.1 Overview

    9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9.5 Hematology

    9.5.1 Overview

    9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9.6 Prenatal Testing

    9.6.1 Overview

    9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9.7 Endocrinology

    9.7.1 Overview

    9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9.8 Others

    9.8.1 Overview

    9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User

    10.1 Overview

    10.2 Point-of-Care Molecular Diagnostics Market, by End User 2021 & 2028 (%)

    10.3 Hospitals and Clinics

    10.3.1 Overview

    10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    10.4 Diagnostic Laboratories

    10.4.1 Overview

    10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    10.5 Research and Academic Institutes

    10.5.1 Overview

    10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    10.6 Others

    10.6.1 Overview

    10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11. Global Point-of-Care Molecular Diagnostics Market – Geographic Analysis

    11.1 North America: Point-of-Care Molecular Diagnostics Market

    11.1.1 Overview

    11.1.2 North America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

    11.1.3 North America Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    11.1.4 North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    11.1.5 North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

    11.1.6 North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    11.1.7 North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

    11.1.7.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.1.7.1.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.1.7.1.2 US Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    11.1.7.1.3 US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    11.1.7.1.4 US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

    11.1.7.1.5 US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    11.1.7.2 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.1.7.2.1 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.1.7.2.2 Canada Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    11.1.7.2.3 Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    11.1.7.2.4 Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

    11.1.7.2.5 Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    11.1.7.3 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.1.7.3.1 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.1.7.3.2 Mexico Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    11.1.7.3.3 Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    11.1.7.3.4 Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

    11.1.7.3.5 Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    11.2 Europe: Point-of-Care Molecular Diagnostics Market

    11.2.1 Overview

    11.2.2 Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.2.3 Europe: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)

    11.2.4 Europe: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)

    11.2.5 Europe: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)

    11.2.6 Europe: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)

    11.2.7 Europe: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)

    11.2.7.1 UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.2.7.1.1 UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.2.7.1.2 UK: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

    11.2.7.1.3 UK: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

    11.2.7.1.4 UK: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

    11.2.7.1.5 UK: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

    11.2.7.2 Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.2.7.2.1 Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.2.7.2.2 Germany: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

    11.2.7.2.3 Germany: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

    11.2.7.2.4 Germany: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

    11.2.7.2.5 Germany: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

    11.2.7.3 France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.2.7.3.1 France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.2.7.3.2 France: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

    11.2.7.3.3 France: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

    11.2.7.3.4 France: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

    11.2.7.3.5 France: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

    11.2.7.4 Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.2.7.4.1 Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.2.7.4.2 Italy: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

    11.2.7.4.3 Italy: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

    11.2.7.4.4 Italy: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

    11.2.7.4.5 Italy: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

    11.2.7.5 Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.2.7.5.1 Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.2.7.5.2 Spain: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

    11.2.7.5.3 Spain: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

    11.2.7.5.4 Spain: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

    11.2.7.5.5 Spain: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

    11.2.7.6 Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.2.7.6.1 Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.2.7.6.2 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

    11.2.7.6.3 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

    11.2.7.6.4 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

    11.2.7.6.5 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

    11.3 Asia Pacific: Point-of-Care Molecular Diagnostics Market

    11.3.1 Overview

    11.3.2 Asia Pacific: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

    11.3.3 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    11.3.4 Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    11.3.5 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

    11.3.6 Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    11.3.7 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

    11.3.7.1 China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.3.7.1.1 China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.3.7.1.2 China: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    11.3.7.1.3 China Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    11.3.7.1.4 China: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

    11.3.7.1.5 China Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    11.3.7.2 Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.3.7.2.1 Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.3.7.2.2 Japan: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    11.3.7.2.3 Japan Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    11.3.7.2.4 Japan: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

    11.3.7.2.5 Japan Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    11.3.7.3 India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.3.7.3.1 India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.3.7.3.2 India: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    11.3.7.3.3 India Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    11.3.7.3.4 India: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

    11.3.7.3.5 India Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    11.3.7.4 Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.3.7.4.1 Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.3.7.4.2 Australia: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    11.3.7.4.3 Australia Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    11.3.7.4.4 Australia: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

    11.3.7.4.5 Australia Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    11.3.7.5 South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.3.7.5.1 South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.3.7.5.2 South Korea: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    11.3.7.5.3 South Korea Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    11.3.7.5.4 South Korea: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

    11.3.7.5.5 South Korea Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    11.3.7.6 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.3.7.6.1 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    11.3.7.6.2 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    11.3.7.6.3 Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    11.3.7.6.4 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)

    11.3.7.6.5 Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    11.4 Middle East & Africa: Point-of-Care Molecular Diagnostics Market

    11.4.1 Overview

    11.4.2 Middle East & Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.4.3 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)

    11.4.4 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)

    11.4.5 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)

    11.4.6 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)

    11.4.7 Middle East & Africa: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)

    11.4.7.1 Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.4.7.1.1 Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.4.7.1.2 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

    11.4.7.1.3 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

    11.4.7.1.4 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

    11.4.7.1.5 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

    11.4.7.2 South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.4.7.2.1 South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.4.7.2.2 South Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

    11.4.7.2.3 South Africa: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

    11.4.7.2.4 South Africa: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

    11.4.7.2.5 South Africa: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

    11.4.7.3 UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.4.7.3.1 UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.4.7.3.2 UAE: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

    11.4.7.3.3 UAE: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

    11.4.7.3.4 UAE: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

    11.4.7.3.5 UAE: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

    11.4.7.4 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.4.7.4.1 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.4.7.4.2 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

    11.4.7.4.3 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

    11.4.7.4.4 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

    11.4.7.4.5 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

    11.5 South and Central America: Point-of-Care Molecular Diagnostics Market

    11.5.1 Overview

    11.5.2 South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.5.3 South and Central America: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)

    11.5.4 South and Central America: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)

    11.5.5 South and Central America: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)

    11.5.6 South and Central America: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)

    11.5.7 South and Central America: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)

    11.5.7.1 Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.5.7.1.1 Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.5.7.1.2 Brazil: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

    11.5.7.1.3 Brazil: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

    11.5.7.1.4 Brazil: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

    11.5.7.1.5 Brazil: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

    11.5.7.2 Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.5.7.2.1 Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.5.7.2.2 Argentina: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

    11.5.7.2.3 Argentina: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

    11.5.7.2.4 Argentina: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

    11.5.7.2.5 Argentina: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

    11.5.7.3 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.5.7.3.1 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    11.5.7.3.2 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)

    11.5.7.3.3 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)

    11.5.7.3.4 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)

    11.5.7.3.5 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)

    12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market

    12.1 Overview – Impact of COVID-19

    12.2 Impact of COVID-19 on Point-of-Care Molecular Diagnostic Market

    12.3 North America: Impact Assessment of COVID-19 Pandemic

    12.4 Europe: Impact Assessment of COVID-19 Pandemic

    12.5 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    12.6 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

    12.7 South and Central America: Impact Assessment of COVID-19 Pandemic

    13. Point-of-Care Molecular Diagnostics Market– Industry Landscape

    13.1 Overview

    13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

    13.3 Organic Growth Strategies

    13.3.1 Overview

    13.4 Inorganic Growth Strategies

    13.4.1 Overview

    14. Company Profiles

    14.1 F. Hoffmann-La Roche Ltd.

    14.1.1 Key Facts

    14.1.2 Business Description

    14.1.3 Products and Services

    14.1.4 Financial Overview

    14.1.5 SWOT Analysis

    14.1.6 Key Developments

    14.2 bioMérieux SA

    14.2.1 Key Facts

    14.2.2 Business Description

    14.2.3 Products and Services

    14.2.4 Financial Overview

    14.2.5 SWOT Analysis

    14.2.6 Key Developments

    14.3 Abbott

    14.3.1 Key Facts

    14.3.2 Business Description

    14.3.3 Products and Services

    14.3.4 Financial Overview

    14.3.5 SWOT Analysis

    14.3.6 Key Developments

    14.4 MERIDIAN BIOSCIENCE, INC.

    14.4.1 Key Facts

    14.4.2 Business Description

    14.4.3 Products and Services

    14.4.4 Financial Overview

    14.4.5 SWOT Analysis

    14.4.6 Key Developments

    14.5 Enzo Biochem Inc.

    14.5.1 Key Facts

    14.5.2 Business Description

    14.5.3 Products and Services

    14.5.4 Financial Overview

    14.5.5 SWOT Analysis

    14.5.6 Key Developments

    14.6 Biocartis

    14.6.1 Key Facts

    14.6.2 Business Description

    14.6.3 Products and Services

    14.6.4 Financial Overview

    14.6.5 SWOT Analysis

    14.6.6 Key Developments

    14.7 Quidel Corporation

    14.7.1 Key Facts

    14.7.2 Business Description

    14.7.3 Products and Services

    14.7.4 Financial Overview

    14.7.5 SWOT Analysis

    14.7.6 Key Developments

    14.8 Danaher

    14.8.1 Key Facts

    14.8.2 Business Description

    14.8.3 Products and Services

    14.8.4 Financial Overview

    14.8.5 SWOT Analysis

    14.8.6 Key Developments

    14.9 BIO-RAD LABORATORIES INC.

    14.9.1 Key Facts

    14.9.2 Business Description

    14.9.3 Products and Services

    14.9.4 Financial Overview

    14.9.5 SWOT Analysis

    14.9.6 Key Developments

    14.10 binx health, inc.

    14.10.1 Key Facts

    14.10.2 Business Description

    14.10.3 Products and Services

    14.10.4 Financial Overview

    14.10.5 SWOT Analysis

    14.10.6 Key Developments

    15. Appendix

    15.1 About The Insight Partners

    15.2 Glossary of Terms

    LIST OF TABLES

    Table 1. North America Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    Table 2. North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    Table 3. North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 4. North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 5. US Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    Table 6. US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    Table 7. US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 8. US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 9. Canada Point-of-Care Molecular Diagnostics Market, by Product and Services -Revenue and Forecast to 2028 (USD Million)

    Table 10. Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    Table 11. Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 12. Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 13. Mexico Point-of-Care Molecular Diagnostics Market, by Product and Services -Revenue and Forecast to 2028 (USD Million)

    Table 14. Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    Table 15. Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 16. Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 17. Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 18. Europe: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 19. Europe: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 20. Europe: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 21. UK: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 22. UK: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 23. UK: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 24. UK: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 25. Germany: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 26. Germany: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 27. Germany: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 28. Germany: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 29. France: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 30. France: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 31. France: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 32. France: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 33. Italy: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 34. Italy: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 35. Italy: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 36. Italy: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 37. Spain: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 38. Spain: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 39. Spain: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 40. Spain: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 41. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 42. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 43. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 44. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 45. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    Table 46. Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    Table 47. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 48. Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 49. China: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    Table 50. China Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    Table 51. China: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 52. China Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 53. Japan: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    Table 54. Japan Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    Table 55. Japan: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 56. Japan Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 57. India: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    Table 58. India Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    Table 59. India: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 60. India Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 61. Australia: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    Table 62. Australia Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    Table 63. Australia: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 64. Australia Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 65. South Korea: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    Table 66. South Korea Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    Table 67. South Korea: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 68. South Korea Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 69. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)

    Table 70. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    Table 71. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 72. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

    Table 73. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 74. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 75. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 76. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 77. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 78. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 79. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 80. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 81. South Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 82. South Africa: Point-of-Care Molecular Diagnostics Market, By Technology - Revenue and Forecast to 2028 (US$ Million)

    Table 83. South Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 84. South Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 85. UAE: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 86. UAE: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 87. UAE: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 88. UAE: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 89. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 90. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 91. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 92. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 93. South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 94. South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 95. South and Central America: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 96. South and Central America: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 97. Brazil: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 98. Brazil: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 99. Brazil: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 100. Brazil: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 101. Argentina: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 102. Argentina: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 103. Argentina: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 104. Argentina: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 105. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)

    Table 106. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)

    Table 107. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)

    Table 108. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)

    Table 109. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market

    Table 110. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market

    Table 111. Glossary of Terms, Point-of-Care Molecular Diagnostics Market

    LIST OF FIGURES

    Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation

    Figure 2. Point-of-Care Molecular Diagnostics Market Segmentation, By Region

    Figure 3. Global Point-of-Care Molecular Diagnostics Market Overview

    Figure 4. Assays and Kits Segment Held the Largest Share by Product and Services in Point-of-Care Molecular Diagnostics Market

    Figure 5. Asia Pacific to Show Significant Growth During Forecast Period

    Figure 6. Point-of-Care Molecular Diagnostics Market, by Geography (US$ Million)

    Figure 7. Global Point-of-Care Molecular Diagnostics Market– Leading Country Markets (US$ Million)

    Figure 8. Global Point-of-Care Molecular Diagnostics Market, Industry Landscape

    Figure 9. North America PEST Analysis

    Figure 10. Europe and PEST Analysis

    Figure 11. Asia Pacific PEST Analysis

    Figure 12. Middle East and Africa PEST Analysis

    Figure 13. South and Central America (SCAM) PEST Analysis

    Figure 14. Global Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

    Figure 15. Global Point-of-Care Molecular Diagnostics Market – By Geography Forecast and Analysis – 2021- 2028

    Figure 16. Market Positioning of Key Players in Global Point-of-Care Molecular Diagnostics Market

    Figure 17. Point-of-Care Molecular Diagnostics Market, by Product and Services 2021 & 2028 (%)

    Figure 18. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 19. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 20. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 21. Point-of-Care Molecular Diagnostics Market, by Technology 2021 & 2028 (%)

    Figure 22. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 23. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 24. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 25. Point-of-Care Molecular Diagnostics Market, by Application 2021 & 2028 (%)

    Figure 26. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 27. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 28. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 29. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 30. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 31. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 32. Point-of-Care Molecular Diagnostics Market, by End User 2021 & 2028 (%)

    Figure 33. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 34. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 35. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 36. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 37. North America: Point-of-Care Molecular Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

    Figure 38. North America Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)

    Figure 39. North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

    Figure 40. US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 41. Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 42. Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 43. Europe: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)

    Figure 44. Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 45. Europe: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)

    Figure 46. UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 47. Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 48. France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 49. Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 50. Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 51. Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 52. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

    Figure 53. Asia Pacific: Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)

    Figure 54. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

    Figure 55. China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 56. Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 57. India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 58. Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 59. South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 60. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

    Figure 61. Middle East & Africa: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)

    Figure 62. Middle East & Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 63. Middle East & Africa: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)

    Figure 64. Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 65. South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 66. UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 67. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 68. South and Central America: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)

    Figure 69. South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 70. South and Central America: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)

    Figure 71. Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 72. Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 73. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 74. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in North America

    Figure 75. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Europe

    Figure 76. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Asia-Pacific

    Figure 77. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Middle East and Africa

    Figure 78. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in South and Central America

    Figure 79. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

    The List of Companies - Point-of-Care Molecular Diagnostics Market

    1. bioMérieux SA
    2.  F. Hoffmann-La Roche Ltd.
    3. Danaher Corporation
    4.  Enzo Biochem, Inc.
    5. Abbott
    6. binx health, Inc.
    7. Meridian BioScience, Inc.
    8. Biocartis
    9. Quidel Corporation
    10. Bio-Rad Laboratories, Inc.
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the point-of-care molecular diagnostics market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global point-of-care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
    TIPRE00003144
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market



    Frequently Asked Questions

    Point-of-care molecular diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood, serum, and stool. Molecular diagnostics are shifting from centralized laboratories to decentralized point-of-care molecular testing, due to its simplicity, convenience, rapid turnaround time, and potential to improve patient outcomes.
    Increasing demand for diagnostic tools to control and eliminate infectious diseases, timely detection of causative agent, allowing effective treatment and disease control will fuel the market during the forecast period.
    Various companies have made organic growth strategies in the point-of-care molecular diagnostics market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as F. Hoffmann-La Roche Ltd, Danaher amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.
    North America dominates the global point-of-care molecular diagnostics market. Ongoing efforts by major market participants to strengthen their market position is an important factor contributing to the major share. Furthermore, several clinical studies investigating the efficiency and accuracy of novel molecular tests are also expected to contribute towards the market growth over the forecast period. Growing demand for rapid diagnosis and development of newer molecular diagnostic tests for DNA analysis have poised the region as a major market space.
    In 2021, the assays and kits segment is estimated to account for the largest market share in the global point-of-care molecular diagnostics market. POC molecular diagnostic assays and kits are specially designed for point of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts. POC molecular diagnostics assays and kits enable the early diagnosis of infectious diseases, cancer, and women’s health and sexual health conditions among others.
    Asia Pacific is expected to be the fastest growing region in the point-of-care molecular diagnostics market. The growth of the point-of-care molecular diagnostics market in this region is primarily due to rising incidences of chronic diseases associated with geriatric population, expansion of key market players in this region, insufficient sophisticated central laboratory testing services, and potential cost effectiveness of POC molecular diagnosis.

    Pricing
    • $3000
    • $4550
    • $6550
    • $8550

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst